[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Corporate Strategies in Consumer Health (World)

November 2012 | 64 pages | ID: C35572E014AEN
Euromonitor International Ltd

US$ 2,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Euromonitor International examines the strategies shaping the consumer health industry in 2012 and beyond. Included is an in-depth breakdown of the macro trends driving success and failure in the industry, and how the top companies and brands are reacting, in order to best position themselves for long-term growth. This briefing also includes in-depth analyses of the mergers and acquisitions market, the evolving regulatory landscape, and trends in research and development.

Euromonitor International’s Corporate Strategies in Consumer Health (World) global briefing examines the size, growth trends and potential opportunities in the Consumer Health market.  The strategic analyses include assessing the impacts of changing regulations, research breakthroughs and public health concerns on both the market and leading companies.  Consumer attitudes towards the products and their personal healthcare needs are also explored.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Consumer Health market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Introduction
Company Performance   Summary
Brand Performance   Summary
Mergers and Acquisitions
The Evolving Regulatory Landscape
Rx-to- otc Switches
Research and Development
Conclusion
DefinitionS
Definitions
Appendix


More Publications